Clin2
NCT06801808Possibly a fitNot yet recruiting

HMB supplement for muscle strength in sarcopenia patients

Sarcopenia

Part of Brain & nervous system clinical trials.

This study tests whether a daily supplement called HMB (a natural substance found in some foods) can help improve walking and strength in people with sarcopenia (age-related muscle loss) who have recently spent time in bed. If you are between 50 and 99 years old and have weak muscles, this trial might help you regain function.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
50 years to 99 years
Study type
Interventional

Who can take part

  • You are between 50 and 99 years old.
  • You have been diagnosed with sarcopenia (age-related muscle loss) by a doctor.
  • You can walk on your own or with a little help.
  • You have had a period of bed rest lasting at least 5 days.
  • You are not taking blood thinners and do not have kidney or liver disease.
  • You are able to understand and follow simple instructions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06736249Recruiting
Testing a new treatment for muscle loss in sarcopenia

This trial tests a new approach to treat sarcopenia (age-related muscle loss) by targeting a protein called HIF-1α. It compares older adults with sarcopenia to younger adults without it, all of whom are having hip or knee surgery.

Milan, Europe
NCT07749118Recruiting
Study of HB05P for muscle health in older adults

This study tests a food product called HB05P to see if it can help improve muscle strength and physical function in people with low muscle mass. It includes a supervised exercise program and may help you maintain independence as you age.

Yangsan
NCT07072195Recruiting· Phase 2
A study of AMC6156 for people with muscle loss

This trial tests an investigational drug called AMC6156 to see if it can help improve muscle mass and strength in older adults with sarcopenia (age-related muscle loss). Participants will also follow exercise and nutrition guidance.

Seongnam-si, Gyeonggi-do
NCT03649698Recruiting
Exercise and nutrition plan for loss of muscle with aging

This trial studies whether a structured exercise and nutrition program can improve muscle health in older adults with (pre)sarcopenia, especially those who may have slower walking or reduced strength. It also checks safety by excluding people with unstable health problems and several specific medical conditions.

Leuven, Vlaams-Brabant
NCT07049731Not yet recruiting
Protein powder and exercise for muscle health in sarcopenia

This trial tests whether adding protein powder to a resistance exercise program can improve muscle strength and mobility in people with sarcopenia, a condition of age-related muscle loss. It is designed for adults aged 35–75 who have low muscle strength and slow walking speed or other physical performance issues.

Beijing
NCT05525039Recruiting
Vibration plus supplement trial for weak muscles and nerves

This trial studies whether a vibration treatment combined with an HMB supplement can improve weak muscle quality and reduce early nerve-to-muscle connection problems. It is mainly for older adults who already have signs of low muscle strength or function.

Hong Kong

Hear when a new Sarcopenia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.